SILK ROAD MEDICAL INC (SILK)       53.75  +0.5 (+0.94%)

53.75  +0.5 (+0.94%)

US82710M1009 - Common Stock

SILK ROAD MEDICAL INC53.75

NASDAQ:SILK (12/1/2022, 10:59:47 AM)+0.5 (+0.94%)

Chartmill TA Rating
Chartmill Setup Rating
Sector
GICS Sector Health Care
GICS Industry Health Care Equipment & Supplies
Chartmill FA Rating
Valuation Growth
Profitability Health
Dividend
Overview
Earnings (Last) 11-08 2022-11-08/amc Earnings (Next) 02-22 2023-02-22
Ins Owners 2.62% Inst Owners 92.34%
Market Cap 2.05B Shares 38.12M
PE N/A Fwd PE N/A
Dividend Yield N/A Analysts 80
IPO 04-04 2019-04-04

Stock Screener Links

Screen Image

Nasdaq Stock Screener

Find more stocks on Nasdaq

Screen Image

USA Stock Screener

Find more stocks on the USA

Screen Image

GICS Sector Stock Screener

Find competitors from the same sector on the USA

Screen Image

GICS Industry Stock Screener

Find competitors from the same industry on the USA

Screen Image

Technical Stock Screener

Find stocks with similar TA and Setup ratings on the USA

Screen Image

Fundamental Stock Screener

Find stocks with similar Fundamental rating on the USA

Screen Image

Best Technical Competitors Stock Screener

Find the competitors with the best technical ratings on the USA

Screen Image

Best Technical Setups Competitors Stock Screener

Find the competitors with the best technical and setup ratings on the USA

Screen Image

Best Fundamental Competitors Stock Screener

Find the competitors with the best fundamentals on the USA

Screen Image

Best Valuation Competitors Stock Screener

Find the competitors with the best valuation on the USA

Screen Image

Best Dividend Competitors Stock Screener

Find the competitors with the best dividend on the USA

Screen Image

Best Analyst Rating Competitors Stock Screener

Find the competitors with the best analyst ratings on the USA

SILK Daily chart

Company Profile

Silk Road Medical, Inc. develops and manufactures medical devices to treat neurovascular diseases. The company is headquartered in Sunnyvale, California and currently employs 352 full-time employees. The company went IPO on 2019-04-04. The firm has discovered an approach for the treatment of carotid artery disease called TransCarotid Artery Revascularization (TCAR), which relies on two concepts: minimally invasive direct carotid access in the neck and high-rate blood flow reversal during the procedure to protect the brain and combines the benefits of innovative endovascular techniques with fundamental surgical principles. The firm's ENROUTE Transcarotid Neuroprotection System (NPS) and ENROUTE Transcarotid Stent System are the products for use in TCAR. Its ENROUTE Transcarotid Stent System is placed during a period of temporary high-rate blood flow reversal, which is enabled by its ENROUTE Transcarotid NPS. The company markets and sells its products in the United States through a direct sales organization consisting of approximately 64 sales representatives and 62 clinical support specialists.

Company Info

SILK ROAD MEDICAL INC

1213 Innsbruck Dr

Sunnyvale CALIFORNIA 94089

P: 16505669060.0

CEO: Erica J. Rogers

Employees: 352

Website: https://silkroadmed.com/

SILK News

News Image23 days ago - Silk Road MedicalSilk Road Medical Reports Third Quarter 2022 Financial ResultsNews Imagea month ago - Silk Road MedicalSilk Road Medical to Present at Upcoming Investor Conferences

 SUNNYVALE, Calif., Nov. 03, 2022 (GLOBE NEWSWIRE) --  Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its...

News Imagea month ago - Silk Road MedicalSilk Road Medical to Present at Upcoming Investor ConferencesNews Imagea month ago - Silk Road MedicalSilk Road Medical to Report Third Quarter 2022 Financial Results on November 8, 2022

SUNNYVALE, Calif., Oct. 25, 2022 (GLOBE NEWSWIRE) -- Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its...

News Imagea month ago - Silk Road MedicalSilk Road Medical to Report Third Quarter 2022 Financial Results on November 8, 2022News Imagea month ago - Market News VideoInvestors Snatch SILK Even Cheaper Than Its Secondary Stock Offering

SILK Twits

Here you can normally see the latest stock twits on SILK, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.

Example Twits:

Twits example